Beacon Biosignals

beacon.bio

Beacon Biosignals is a pioneering company focused on enhancing precision medicine for neurological and psychiatric conditions through its EEG neurobiomarker platform. The platform accelerates clinical trials and enables new treatments by providing quantitative assessments of treatment efficacy, optimizing dose selection, and stratifying patient populations. With a combination of FDA-cleared medical devices, advanced machine learning algorithms, and a comprehensive clinico-EEG database, Beacon differentiates itself in the market by offering scalable solutions that improve the probability of success in drug development. The company partners with biopharma firms and academic institutions to drive innovation in brain health, positioning itself as a leader in the field with significant traction in clinical research.